AAAAAA
Results: 1-25/29
Authors:
Schlitt, HJ
Barkmann, A
Boker, KHW
Schmidt, HHJ
Emmanouilidis, N
Rosenau, J
Bahr, MJ
Tusch, G
Manns, MP
Nashan, B
Klempnauer, J
Citation: Hj. Schlitt et al., Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study, LANCET, 357(9256), 2001, pp. 587-591
Authors:
Kirchner, GI
Jacobsen, W
Deters, M
Christians, U
Nashan, B
Winkler, M
Vidal, C
Kaever, V
Sewing, KF
Manns, MP
Citation: Gi. Kirchner et al., Fast quantification method for sirolimus and its major metabolites, TRANSPLAN P, 33(1-2), 2001, pp. 1091-1092
Authors:
Tippner, C
Nashan, B
Hoshino, K
Schmidt-Sandte, E
Akimaru, K
Boker, KHW
Schlitt, HJ
Citation: C. Tippner et al., Clinical and subclinical acute rejection early after liver transplantation- Contributing factors and relevance for the long-term course, TRANSPLANT, 72(6), 2001, pp. 1122-1128
Authors:
Bumgardner, GL
Hardie, I
Johnson, RWG
Lin, A
Nashan, B
Pescovitz, MD
Ramos, E
Vincenti, F
Citation: Gl. Bumgardner et al., Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation., TRANSPLANT, 72(5), 2001, pp. 839-845
Authors:
Vincenti, F
Ramos, E
Brattstrom, C
Cho, S
Ekberg, H
Grinyo, J
Johnson, R
Kuypers, D
Stuart, F
Khanna, A
Navarro, M
Nashan, B
Citation: F. Vincenti et al., Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation, TRANSPLANT, 71(9), 2001, pp. 1282-1287
Authors:
Kovarik, JM
Nashan, B
Neuhaus, P
Clavien, PA
Gerbeau, C
Hall, ML
Korn, A
Citation: Jm. Kovarik et al., A population pharmacokinetic screen to identify demographic-clinical covariates of basiliximab in liver transplantation, CLIN PHARM, 69(4), 2001, pp. 201-209
Authors:
Schult, M
Kuster, J
Kliem, V
Brunkhorst, R
Nashan, B
Oldhafer, KJ
Schlitt, HJ
Citation: M. Schult et al., Native pyeloureterostomy after kidney transplantation: experience in 48 cases, TRANSPLAN I, 13(5), 2000, pp. 340-343
Authors:
Ekberg, H
Backman, L
Tufveson, G
Tyden, G
Nashan, B
Vincenti, F
Citation: H. Ekberg et al., Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis, TRANSPLAN I, 13(2), 2000, pp. 151-159
Authors:
Nashan, B
Citation: B. Nashan, Secondary neoplasms following liver and pancreas transplantation, CONTR ONCOL, 55, 2000, pp. 256-263
Authors:
Strehlau, J
Pape, L
Offner, G
Nashan, B
Ehrich, JHH
Citation: J. Strehlau et al., Interleukin-2 receptor antibody-induced alterations of ciclosporin dose requirements in paediatric transplant recipients, LANCET, 356(9238), 2000, pp. 1327-1328
Authors:
Thistlethwaite, JR
Nashan, B
Hall, M
Chodoff, L
Lin, TH
Citation: Jr. Thistlethwaite et al., Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus, TRANSPLANT, 70(5), 2000, pp. 784-790
Authors:
Barkmann, A
Nashan, B
Schmidt, HHJ
Boker, KHW
Emmanouilidis, N
Rosenau, J
Bahr, MJ
Hoffmann, MW
Manns, MP
Klempnauer, J
Schlitt, HJ
Citation: A. Barkmann et al., Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil, TRANSPLANT, 69(9), 2000, pp. 1886-1890
Authors:
Lang, H
Schlitt, HJ
Schmidt, H
Flemming, P
Nashan, B
Scheumann, GFW
Oldhafer, KJ
Manns, MP
Raab, R
Citation: H. Lang et al., Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients, LANG ARCH S, 384(4), 1999, pp. 370-377
Authors:
Demirci, G
Hoshino, K
Nashan, B
Citation: G. Demirci et al., Expression patterns of integrin receptors and extracellular matrix proteins in chronic rejection of human liver allografts, TRANSPL IMM, 7(4), 1999, pp. 229-237
Authors:
Schlitt, HJ
Neipp, M
Weimann, A
Oldhafer, KJ
Schmoll, E
Boeker, K
Nashan, B
Kubicka, S
Maschek, H
Tusch, G
Raab, R
Ringe, B
Manns, MP
Pichlmayr, R
Citation: Hj. Schlitt et al., Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation, J CL ONCOL, 17(1), 1999, pp. 324-331
Authors:
Marx, G
Nashan, B
Meyer, MC
Vangerow, B
Schlitt, HJ
Ziesing, S
Leuwer, M
Piepenbrock, S
Rueckoldt, H
Citation: G. Marx et al., Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor, INTEN CAR M, 25(9), 1999, pp. 1017-1020
Authors:
Schmidt, HHJ
Nashan, B
Propsting, MJ
Nakazato, M
Flemming, P
Kubicka, S
Boker, K
Pichlmayr, R
Manns, MP
Citation: Hhj. Schmidt et al., Familial amyloidotic polyneuropathy: domino liver transplantation, J HEPATOL, 30(2), 1999, pp. 293-298
Authors:
Widjaja, A
Wagner, S
Mix, H
Rifai, K
Rambusch, E
Stolte, M
Meier, PN
Nashan, B
Reimann, J
Boker, K
Heil, G
Manns, MP
Citation: A. Widjaja et al., Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma, Z GASTROENT, 37(7), 1999, pp. 611-614
Authors:
Nashan, B
Citation: B. Nashan, The interleukin-2 inhibitors and their role in low-toxicity regimens, TRANSPLAN P, 31(8A), 1999, pp. 23S-26S
Authors:
Vincenti, F
Grinyo, J
Ramos, E
Nashan, B
Stuart, F
Kuypers, D
Brattstrom, C
Cho, S
Ekberg, H
Johnson, R
Citation: F. Vincenti et al., Can antibody prophylaxis allow sparing of other immunosuppressives?, TRANSPLAN P, 31(1-2), 1999, pp. 1246-1248
Authors:
Kliem, V
Boeck, A
Eisenberger, U
Petersen, R
Radermacher, J
Hiss, M
Pethig, M
Koch, KM
Nashan, B
Brunkhorst, R
Citation: V. Kliem et al., Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: Single-center experience in 40 patients, TRANSPLAN P, 31(1-2), 1999, pp. 1312-1313
Authors:
Schlitt, HJ
Brunkhorst, R
Schmidt, HHJ
Nashan, B
Haverich, A
Raab, R
Citation: Hj. Schlitt et al., Attitudes of patients before and after transplantation towards various allografts, TRANSPLANT, 68(4), 1999, pp. 510-514
Authors:
Schult, M
Lohmann, D
Knitsch, W
Kuse, ER
Nashan, B
Citation: M. Schult et al., Recurrent cardiocirculatory arrest after kidney transplantation related tointravenous methylprednisolone bolus therapy, TRANSPLANT, 67(11), 1999, pp. 1497-1498
Authors:
Nashan, B
Light, S
Hardie, IR
Lin, A
Johnson, JR
Citation: B. Nashan et al., Reduction of acute renal allograft rejection by daclizumab, TRANSPLANT, 67(1), 1999, pp. 110-115
Authors:
Nashan, B
Citation: B. Nashan, Basiliximab - A viewpoint, DRUGS, 57(2), 1999, pp. 214-214